Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 500 results in range #1 to #500.

View (previous 500 | ) (20 | 50 | 100 | 250 | 500)

  1. ACTN3 (gene) (1 revision)
  2. ADP-specific glucokinase (1 revision)
  3. AMBP (1 revision)
  4. ADAMTS2 (1 revision)
  5. ALS2CR8 (1 revision)
  6. 60S ribosomal protein L23a (1 revision)
  7. AATK (1 revision)
  8. "sandbox:FZ" (1 revision)
  9. "sandbox:JDS" (1 revision)
  10. "sandbox:M.S" (1 revision)
  11. ADCK3 (1 revision)
  12. ANKRD26 (1 revision)
  13. "sandbox:S.I" (1 revision)
  14. APBA2BP (1 revision)
  15. "sandbox:WA" (1 revision)
  16. 8-cell stage (1 revision)
  17. "template:A.M" (1 revision)
  18. "template:A.R" (1 revision)
  19. "template:AM" (1 revision)
  20. "template:AMS" (1 revision)
  21. AGPAT5 (1 revision)
  22. "template:ArashM" (1 revision)
  23. "template:CA" (1 revision)
  24. "template:F.K" (1 revision)
  25. "template:FI" (1 revision)
  26. "template:Fereshteh karegar (1 revision)
  27. ACACB (1 revision)
  28. APOBEC2 (1 revision)
  29. AP4S1 (1 revision)
  30. APOL1 (1 revision)
  31. "template:S.C" (1 revision)
  32. "template:Saba Iqbal" (1 revision)
  33. "template:Saba Iqbal.awan" (1 revision)
  34. "template:W.A" (1 revision)
  35. "template:WA" (1 revision)
  36. ABCC9 (1 revision)
  37. '''Dr.Prof. Mohammed Abdulwahab AlKhateeb''' -- MD.,FICMS.,-CHIEF CONSULTATNT IN GENERAL INTERNAL MEDICINE, CARDIOLOGY & HEPATOBILIARY DISEASES (1 revision)
  38. ADEPT (1 revision)
  39. ''sandbox:M.S" (1 revision)
  40. ALPPL2 (1 revision)
  41. 'Lab Lemco' powder (1 revision)
  42. (-)-1-Phenyl-2-propylaminopentane (1 revision)
  43. AIR synthetase (FGAM cyclase) (1 revision)
  44. (-)-2β-Carbomethoxy-3β-phenyltropane (1 revision)
  45. (-)-Methyl-1-methyl-4β-(2-naphthyl)piperidine-3β-carboxylate (1 revision)
  46. ALG12 (1 revision)
  47. ALPHA (psychedelic) (1 revision)
  48. AMA Physician Masterfile (1 revision)
  49. AMG-36 (1 revision)
  50. ANGPTL1 (1 revision)
  51. AMOTL2 (1 revision)
  52. ANKRD15 (1 revision)
  53. -omics (1 revision)
  54. 0-0-1-3 (1 revision)
  55. 0-3 (1 revision)
  56. 1,1'-Bi-2-naphthol (1 revision)
  57. 1,1'-bi-2-naphthol (1 revision)
  58. 1,1,2,2-Tetrachloroethane (1 revision)
  59. 1,1,2-Trichloroethane (1 revision)
  60. 1,2-Dichloroethane (1 revision)
  61. 1,2-rearrangement (1 revision)
  62. 1,3-Bisphosphoglycerate (1 revision)
  63. 1,3-Butadiene (1 revision)
  64. 1,3-Dipolar cycloaddition (1 revision)
  65. ACTL7A (1 revision)
  66. ACSBG1 (1 revision)
  67. ACSS3 (1 revision)
  68. 1,4-Dichlorobenzene (1 revision)
  69. 1,4-Dioxane (1 revision)
  70. 1,5-Pentanediol (1 revision)
  71. 1,8-Bis(dimethylamino)naphthalene (1 revision)
  72. 1,8-Diazabicycloundec-7-ene (1 revision)
  73. 1-(3-Chlorophenyl)piperazine (1 revision)
  74. ACTL8 (1 revision)
  75. 100% English (1 revision)
  76. 108 form Wu family T'ai Chi Ch'uan (1 revision)
  77. 11-Hydroxy-THC (1 revision)
  78. ADCY10 (1 revision)
  79. ADAMTS4 (1 revision)
  80. 5-MeO-AET (1 revision)
  81. 60S ribosomal protein L7a (1 revision)
  82. AD-mix (1 revision)
  83. 60S ribosomal protein L23 (1 revision)
  84. ANKK1 (1 revision)
  85. A2ML1 (1 revision)
  86. 5-MeO-pyr-T (1 revision)
  87. 60S ribosomal protein L21 (1 revision)
  88. 5-MeO-MiPT (1 revision)
  89. 5-Methoxy-diisopropyltryptamine (1 revision)
  90. ACOT6 (1 revision)
  91. ARHGAP29 (1 revision)
  92. ACO1 (1 revision)
  93. APOLD1 (1 revision)
  94. 7-Amino-actinomycin D (1 revision)
  95. 5-MeO-DET (1 revision)
  96. ADAM18 (1 revision)
  97. 5-Methyltetrahydrofolate-homocysteine methyltransferase (1 revision)
  98. 60S ribosomal protein L13 (1 revision)
  99. APPL2 (1 revision)
  100. 5-alpha-reductase deficiency secondary prevention (1 revision)
  101. 5150 (Involuntary psychiatric hold) (1 revision)
  102. ACCN1 (1 revision)
  103. 13q deletion syndrome (1 revision)
  104. ANXA7 (1 revision)
  105. ANXA11 (1 revision)
  106. ANKRD31 (1 revision)
  107. AM-905 (1 revision)
  108. ACCN3 (1 revision)
  109. 16S ribosomal RNA (1 revision)
  110. APA Task Force on Deceptive and Indirect Techniques of Persuasion and Control (1 revision)
  111. ACCN2 (1 revision)
  112. AQP6 (1 revision)
  113. APC (gene) (1 revision)
  114. APBB3 (1 revision)
  115. 5-alpha-reductase deficiency case study one (1 revision)
  116. 60S ribosomal protein L27a (1 revision)
  117. 60S ribosomal protein L26 (1 revision)
  118. APOBEC4 (1 revision)
  119. ADK (gene) (1 revision)
  120. 5q- syndrome (1 revision)
  121. APTX 4869 (1 revision)
  122. 60S ribosomal protein L14 (1 revision)
  123. ABCB11 (1 revision)
  124. ARD1A (1 revision)
  125. 60S ribosomal protein L4 (1 revision)
  126. A4GALT (1 revision)
  127. ACTL6B (1 revision)
  128. 5-alpha-reductase deficiency surgery (1 revision)
  129. 5-alpha-reductase deficiency primary prevention (1 revision)
  130. AGXT2 (1 revision)
  131. AFF3 (1 revision)
  132. 60S ribosomal protein L41 (1 revision)
  133. 60S ribosomal protein L15 (1 revision)
  134. ADAM17 (1 revision)
  135. ALS Therapy Development Institute (1 revision)
  136. 60S ribosomal protein L17 (1 revision)
  137. 60S ribosomal protein L10 (1 revision)
  138. 60S ribosomal protein L32 (1 revision)
  139. 60S ribosomal protein L18 (1 revision)
  140. 60S ribosomal protein L29 (1 revision)
  141. 60S ribosomal protein L5 (1 revision)
  142. 60S ribosomal protein L28 (1 revision)
  143. ACOT4 (1 revision)
  144. 17-beta-hydroxysteroid dehydrogenase deficiency x ray (1 revision)
  145. 5-MeO-DPT (1 revision)
  146. ADCC (1 revision)
  147. 60S ribosomal protein L35a (1 revision)
  148. 60S ribosomal protein L36a (1 revision)
  149. AGMAT (1 revision)
  150. ADAMTS12 (1 revision)
  151. ABCC12 (1 revision)
  152. ADPRHL2 (1 revision)
  153. ANCA-associated vasculitides (1 revision)
  154. ABHD11 (1 revision)
  155. 60S ribosomal protein L11 (1 revision)
  156. ABI1 (1 revision)
  157. AEGIS II Visit Scheduler (test mode) (1 revision)
  158. 60S ribosomal protein L18a (1 revision)
  159. 60S ribosomal protein L37a (1 revision)
  160. 5-MeO-DMT (1 revision)
  161. ACYP1 (1 revision)
  162. AMY1C (1 revision)
  163. 5-bromouracil (1 revision)
  164. 60S ribosomal protein L12 (1 revision)
  165. 8-Hyydroxyquinoline (1 revision)
  166. 6-Pyruvoyltetrahydropterin synthase deficiency (1 revision)
  167. 68W (1 revision)
  168. AIDSVAX (1 revision)
  169. 18-Methoxycoronaridine (1 revision)
  170. 18S ribosomal RNA (1 revision)
  171. AIG1 (1 revision)
  172. 1993 Clinton health care plan (1 revision)
  173. 1998 Klang Valley water crisis (1 revision)
  174. 1 E-10 m (1 revision)
  175. 1 E-11 m (1 revision)
  176. 1 E7 s (1 revision)
  177. 1p36 deletion syndrome (1 revision)
  178. ALDH3B1 (1 revision)
  179. 2,2,2-Trichloroethanol (1 revision)
  180. 2,2,4-Trimethylpentane (1 revision)
  181. 2,3,4,5-Tetramethoxyamphetamine (1 revision)
  182. 2,3-Bisphosphoglycerate (1 revision)
  183. 2,3-Dihydropyran (1 revision)
  184. 2,3-Dihydroxy-3-methylpentanoic acid (1 revision)
  185. 2,3-squalene oxide (1 revision)
  186. 2,4,5-Trichlorophenoxyacetic acid (1 revision)
  187. ABT-239 (1 revision)
  188. ABTB1 (1 revision)
  189. 2,4-Dichlorophenol (1 revision)
  190. 2,4-Dinitrophenol (1 revision)
  191. AM-4030 (1 revision)
  192. ACACA (1 revision)
  193. ACAA1 (1 revision)
  194. 2,4 Dienoyl-CoA reductase deficiency (1 revision)
  195. AM-938 (1 revision)
  196. 2,5-Dimethoxy-4-ethylamphetamine (1 revision)
  197. 2,5-Dimethoxy-4-iodoamphetamine (1 revision)
  198. 9-1-1 (1 revision)
  199. 2,5-Dimethoxy-4-nitroamphetamine (1 revision)
  200. 2,5-Dimethoxyphenethylamine (1 revision)
  201. 2,5-Dimethylfuran (1 revision)
  202. 60S ribosomal protein L24 (1 revision)
  203. AMP deaminase (1 revision)
  204. ANKFY1 (1 revision)
  205. AM-411 (1 revision)
  206. 2-Acetylaminofluorene (1 revision)
  207. 2-Aminoethoxydiphenyl borate (1 revision)
  208. 2-Aminomuconic acid (1 revision)
  209. ANKRD25 (1 revision)
  210. AARS2 (1 revision)
  211. ANKRD17 (1 revision)
  212. ANP32D (1 revision)
  213. 2-Bromopropane (1 revision)
  214. 2-Butyl-3-(p-tolyl)quinuclidine (1 revision)
  215. 2-Chlorophenol (1 revision)
  216. 2-Ethylhexanol (1 revision)
  217. AP1G1 (1 revision)
  218. 2-Hydroxyglutaricaciduria (1 revision)
  219. 2-Iodoxybenzoic acid (1 revision)
  220. 2-Isopropyl-5-methyl-1-(2,6-dihydroxy-4-nonylphenyl)cyclohex-1-ene (1 revision)
  221. 2-Me-DET (1 revision)
  222. 2-Methyl-2-nitrosopropane (1 revision)
  223. 2-Methyl-3,3-diphenyl-3-propanolamine (1 revision)
  224. 2-Methyl-4-Chlorophenoxyacetic Acid (1 revision)
  225. 2-Methylbutyryl-CoA (1 revision)
  226. 2-Methylbutyryl-CoA dehydrogenase deficiency (1 revision)
  227. 2-Nitropropane (1 revision)
  228. 2-Nonenal (1 revision)
  229. APBB2 (1 revision)
  230. 2-Phenylphenol (1 revision)
  231. 2-Pyridone (1 revision)
  232. 2-Pyrone (1 revision)
  233. 2-chloroethanol (1 revision)
  234. 2-hydroxyphytanoyl-CoA lyase (1 revision)
  235. API oil-water separator (1 revision)
  236. 2-propanoyl-3-(4-isopropylphenyl)-tropane (1 revision)
  237. APOBEC3B (1 revision)
  238. APOF (1 revision)
  239. APOBEC3H (1 revision)
  240. 2007 WikiDoc Foundation Scholars (1 revision)
  241. 5-MeO-NMT (1 revision)
  242. 5-Hydroxyindoleacetic acid (1 revision)
  243. AAVS1 (1 revision)
  244. APPBP2 (1 revision)
  245. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay (1 revision)
  246. AA battery (1 revision)
  247. 60S ribosomal protein L39 (1 revision)
  248. 21-Hydroxylase Deficiency (patient information) (1 revision)
  249. ARHGAP25 (1 revision)
  250. ARF1 (1 revision)
  251. ABCA10 (1 revision)
  252. ACOT1 (1 revision)
  253. ARHGAP31 (1 revision)
  254. Ф29 phage (1 revision)
  255. ACOT11 (1 revision)
  256. ACRRM (1 revision)
  257. ACSF3 (1 revision)
  258. ACSBG2 (1 revision)
  259. ABCA13 (1 revision)
  260. ACSL6 (1 revision)
  261. ACOT7 (1 revision)
  262. ACSM2B (1 revision)
  263. ACS National Historical Chemical Landmarks (1 revision)
  264. ACTIVE A Trial (1 revision)
  265. ACTION (1 revision)
  266. ABCA9 (1 revision)
  267. A-box 1 of insulin gene (1 revision)
  268. ACTR2 (1 revision)
  269. AD-36 (1 revision)
  270. ACY1 (1 revision)
  271. ACTR3 (1 revision)
  272. A1CF (1 revision)
  273. ACTR3B (1 revision)
  274. ADAMTS8 (1 revision)
  275. ABCB8 (1 revision)
  276. ACVR1B (1 revision)
  277. 5-Lipoxygenase activating protein (1 revision)
  278. ADAM12 (1 revision)
  279. 5-alpha-reductase deficiency cost-effectiveness of therapy (1 revision)
  280. AM-855 (1 revision)
  281. ADNP (gene) (1 revision)
  282. 8-Aminoquinoline (1 revision)
  283. AGPAT3 (1 revision)
  284. AFTPH (1 revision)
  285. ACVR1C (1 revision)
  286. ADAM8 (1 revision)
  287. ABCC2 (1 revision)
  288. 5-MeO-DALT (1 revision)
  289. 5-Formamidoimidazole-4-carboxamide ribotide (1 revision)
  290. ABCC4 (1 revision)
  291. 5-alpha-reductase deficiency future or investigational therapies (1 revision)
  292. 60S ribosomal protein L10-like (1 revision)
  293. ADAM15 (1 revision)
  294. ADAM11 (1 revision)
  295. AP2M1 (1 revision)
  296. 5-alpha-reductase deficiency electrocardiogram (1 revision)
  297. 5-Methylcytosine (1 revision)
  298. 5-Hydroxytryptophan (1 revision)
  299. ADAMTSL1 (1 revision)
  300. APOL6 (1 revision)
  301. 5-Methyltetrahydrofolate (1 revision)
  302. 72F fusion protein (1 revision)
  303. ADAMTS17 (1 revision)
  304. 5-MeS-DMT (1 revision)
  305. AAA1 (1 revision)
  306. AAAS (gene) (1 revision)
  307. 22q11.2 deletion syndrome case study one (1 revision)
  308. AFM (gene) (1 revision)
  309. AADAC (1 revision)
  310. 60S ribosomal protein L37 (1 revision)
  311. ADARB2 (1 revision)
  312. ADM2 (1 revision)
  313. AADACL3 (1 revision)
  314. 22q11.2 deletion syndrome echocardiography or ultrasound (1 revision)
  315. AADACL4 (1 revision)
  316. AICDA (1 revision)
  317. ADFP (1 revision)
  318. 5-Methylindole (1 revision)
  319. ALARA (1 revision)
  320. ABHD5 (1 revision)
  321. 60S ribosomal protein L30 (1 revision)
  322. 60S ribosomal protein L19 (1 revision)
  323. AGBL4 (1 revision)
  324. AEBP2 (1 revision)
  325. ADAMTS9 (1 revision)
  326. 5-hydroxytryptophan (1 revision)
  327. ACP1 (1 revision)
  328. ABI gene family member 3 (1 revision)
  329. 60S ribosomal protein L9 (1 revision)
  330. 60S ribosomal protein L8 (1 revision)
  331. AAK (1 revision)
  332. ACTN1 (1 revision)
  333. AGPAT9 (1 revision)
  334. 23andMe (1 revision)
  335. 24-Dehydrocholesterol reductase (1 revision)
  336. AIDA interactive educational freeware diabetes simulator (1 revision)
  337. AIC (gene) (1 revision)
  338. 2C-B (1 revision)
  339. 2C-B-BZP (1 revision)
  340. 2C-B-FLY (1 revision)
  341. AIP (gene) (1 revision)
  342. 2C-D (1 revision)
  343. AIF1 (1 revision)
  344. AKAP2 (1 revision)
  345. AKAP7 (1 revision)
  346. AKAP (1 revision)
  347. 2C-I (1 revision)
  348. AKR1A1 (1 revision)
  349. AKIRIN2 (1 revision)
  350. AKR7A3 (1 revision)
  351. AKR1C4 (1 revision)
  352. ALDH16A1 (1 revision)
  353. ALDH1B1 (1 revision)
  354. ALDH1A3 (1 revision)
  355. ALD-52 (1 revision)
  356. ALDH3A1 (1 revision)
  357. ALDH4A1 (1 revision)
  358. ALDH3B2 (1 revision)
  359. ALDH1L1 (1 revision)
  360. 2C-T-7 (1 revision)
  361. ALDOC (1 revision)
  362. ALDH5A1 (gene) (1 revision)
  363. 2C-TFM (1 revision)
  364. ALG1 (1 revision)
  365. 2R hypothesis (1 revision)
  366. 2b3a (1 revision)
  367. 2nd Skin (1 revision)
  368. ABRA (gene) (1 revision)
  369. 2α-(Propanoyl)-3β-(2-(6-methoxynaphthyl))-tropane (1 revision)
  370. 2β-propanoyl-3β-(2-naphthyl)-tropane (1 revision)
  371. 2β-propanoyl-3β-(4-tolyl)-tropane (1 revision)
  372. ALLHAT trial (1 revision)
  373. ALIVE (1 revision)
  374. ALPK1 (1 revision)
  375. ALOXE3 (1 revision)
  376. 3,4-Diaminopyridine (1 revision)
  377. 3,4-Dimethylamphetamine (1 revision)
  378. ALX1 (1 revision)
  379. ACOT12 (1 revision)
  380. 3-Aminoisobutyric acid (1 revision)
  381. 3-Aminopyridine (1 revision)
  382. AM-087 (1 revision)
  383. 3-Hydroxyacyl ACP dehydrase (1 revision)
  384. AM-906 (1 revision)
  385. AMG-41 (1 revision)
  386. 3-Methylcrotonyl-CoA carboxylase deficiency (1 revision)
  387. AM-919 (1 revision)
  388. AMG-1 (1 revision)
  389. 3-Methylglutaconyl CoA (1 revision)
  390. AM251 (1 revision)
  391. 3-Quinuclidinyl benzilate (1 revision)
  392. 3-Ureidopropionic acid (1 revision)
  393. 3-dehydrosphinganine reductase (1 revision)
  394. AMBN (1 revision)
  395. 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (1 revision)
  396. AMG-3 (1 revision)
  397. ACADL (1 revision)
  398. 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (1 revision)
  399. 3-hydroxyisobutyrate dehydrogenase (1 revision)
  400. ANOVA-simultaneous component analysis (1 revision)
  401. 3-methylglutaconic acid (1 revision)
  402. 310 helix (1 revision)
  403. AMIGO (1 revision)
  404. AMOT (1 revision)
  405. 3C-P (1 revision)
  406. AMPA receptor (1 revision)
  407. 3T3-L1 (1 revision)
  408. 5-HT receptor (1 revision)
  409. 3 beta-hydroxysteroid dehydrogenase deficiency historical perspective (1 revision)
  410. 3 hydroxyisobutyric aciduria (1 revision)
  411. 3 methylcrotonic aciduria (1 revision)
  412. 3c syndrome (1 revision)
  413. 3m syndrome (1 revision)
  414. ANKHD1 (1 revision)
  415. 3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)tropane (1 revision)
  416. ANKRD13C (1 revision)
  417. 4,5-MDO-DMT (1 revision)
  418. 4,5-MDO-DiPT (1 revision)
  419. ACBD3 (1 revision)
  420. ACAT2 (1 revision)
  421. 4-Acetoxy-DET (1 revision)
  422. 4-Acetoxy-DIPT (1 revision)
  423. ANKRD27 (1 revision)
  424. 4-Aminobiphenyl (1 revision)
  425. ACC/AHA guidelines for dextro-transposition of great arteries (1 revision)
  426. 4-Aminoquinoline (1 revision)
  427. 4-Androstene-3,6,17-trione (1 revision)
  428. ANXA4 (1 revision)
  429. AANAT (gene) (1 revision)
  430. AO/OTA classification for the distal tibial Fracture (1 revision)
  431. 4-Chloroindole-3-acetic acid (1 revision)
  432. AOC2 (1 revision)
  433. 4-Dimethylaminophenol (1 revision)
  434. 4-HO-DBT (1 revision)
  435. 4-HO-DET (1 revision)
  436. 4-HO-DPT (1 revision)
  437. 4-HO-DiPT (1 revision)
  438. 4-HO-MET (1 revision)
  439. 4-HO-MPT (1 revision)
  440. 4-HO-pyr-T (1 revision)
  441. 4-Hydroxy-4-methylpentanoic acid (1 revision)
  442. AP1M1 (1 revision)
  443. AP1GBP1 (1 revision)
  444. 4-Hydroxytestosterone (1 revision)
  445. 4-MTA (1 revision)
  446. 4-MeO-MiPT (1 revision)
  447. 4-Methylbenzylidene camphor (1 revision)
  448. AP4M1 (1 revision)
  449. 4-Methylthioamphetamine (1 revision)
  450. 4-Nitroaniline (1 revision)
  451. APBA3 (1 revision)
  452. 4-Oxalocrotonate tautomerase (1 revision)
  453. ACER1 (1 revision)
  454. AASDHPPT (1 revision)
  455. 40S (1 revision)
  456. APC (1 revision)
  457. 40S ribosomal protein S11 (1 revision)
  458. 40S ribosomal protein S12 (1 revision)
  459. 40S ribosomal protein S13 (1 revision)
  460. 40S ribosomal protein S14 (1 revision)
  461. 40S ribosomal protein S15a (1 revision)
  462. APBB1IP (1 revision)
  463. 40S ribosomal protein S18 (1 revision)
  464. 40S ribosomal protein S19 (1 revision)
  465. ACES (nutritional supplement) (1 revision)
  466. ACER3 (1 revision)
  467. ACER2 (1 revision)
  468. 40S ribosomal protein S23 (1 revision)
  469. 40S ribosomal protein S24 (1 revision)
  470. APIP (1 revision)
  471. 40S ribosomal protein S26 (1 revision)
  472. APOBEC3D (1 revision)
  473. 40S ribosomal protein S28 (1 revision)
  474. ACF (gene) (1 revision)
  475. 40S ribosomal protein S3 (1 revision)
  476. ARHGAP27 (1 revision)
  477. 40S ribosomal protein S4, Y isoform 1 (1 revision)
  478. 40S ribosomal protein S4, Y isoform 2 (1 revision)
  479. 40S ribosomal protein S5 (1 revision)
  480. 40S ribosomal protein S7 (1 revision)
  481. 40S ribosomal protein S8 (1 revision)
  482. 40S ribosomal protein S9 (1 revision)
  483. 454 Life Sciences (1 revision)
  484. ADAM28 (1 revision)
  485. 7-Dehydrocholesterol reductase (1 revision)
  486. 999 (emergency telephone number) (1 revision)
  487. AP4E1 (1 revision)
  488. 9q34 deletion syndrome (1 revision)
  489. 5'-3' exoribonuclease 1 (1 revision)
  490. ACKR3 (1 revision)
  491. ARB Project (1 revision)
  492. 5'-Phosphoribosylformylglycinamidine (1 revision)
  493. 5'-phosphoribosyl-4-carboxy-5-aminoimidazole (1 revision)
  494. 5'-phosphoribosyl-5-aminoimidazole (1 revision)
  495. 5' flanking region (1 revision)
  496. 5,10-Methylenetetrahydrofolate (1 revision)
  497. 5,6-MDO-DMT (1 revision)
  498. 5,6-MDO-DiPT (1 revision)
  499. 5,6-MDO-MiPT (1 revision)
  500. 5,6-MeO-MiPT (1 revision)

View (previous 500 | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"